CRH Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of CRH Medical generated cash of $35,993,673, which is less than the previous year. Cash used in financing activities reached the amount of -$14,018,534 last year. Net change in cash is therefore -$2,648,969.
Cash Flow
| 2011 | 1.10M | -34.36K | 663 |
|---|---|---|---|
| 2012 | 1.66M | -17.68K | 0 |
| 2013 | 2.15M | -64.68K | 0 |
| 2014 | 1.38M | -56.70M | 52.85M |
| 2015 | 17.95M | -18.65M | 152.53K |
| 2016 | 32.92M | -30.17M | 3.18M |
| 2017 | 39.53M | -33.27M | -3.27M |
| 2018 | 40.99M | -27.66M | -15.87M |
| 2019 | 45.00M | -20.59M | -27.79M |
| 2020 | 35.99M | -24.62M | -14.01M |
CRH.TO Cash Flow Statement (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 6.56M | 9.94M | 12.48M | 9.50M | 3.57M | 4.13M | 6.60M | 4.51M | 2.86M | 1.79M |
Operating activities | ||||||||||
Net income | -24.47M | 3.77M | 4.67M | 6.55M | 10.56M | 3.07M | 1.49M | 2.49M | 1.33M | 1.19M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 40.65M | 35.00M | 31.48M | 23.80M | 14.93M | 6.85M | 510.62K | 82.12K | 123.25K | 81.71K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 234.64K | 407.24K | 277.34K |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 234.64K | 407.24K | 277.34K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | -5.64M | -2.74M | -1.37M | -176.89K | -113.26K | -92.00K | 0 |
Inventories | 86.85K | 53.22K | 20.90K | -122.68K | -45.83K | 118.46K | -293.85K | 169.67K | -179.67K | 8.19K |
Accounts payable | 0 | 0 | 0 | 2.43M | 195.32K | -3.40M | -996.53K | -26.25K | 69.58K | 29.27K |
Cash generated by operating activities | 35.99M | 45.00M | 40.99M | 39.53M | 32.92M | 17.95M | 1.38M | 2.15M | 1.66M | 1.10M |
Investing activities | ||||||||||
Purchases Of Investments | -2.01M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -42.03K | -59.50K | -35.10K | -125.28K | -113.19K | -184.83K | -95.02K | -64.68K | -17.68K | -34.36K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -24.62M | -20.59M | -27.66M | -33.27M | -30.17M | -18.65M | -56.70M | -64.68K | -17.68K | -34.36K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 20.25M | 4.18M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -862.32K | -4.74M | -3.77M | -2.86M | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -14.29M | 0 | -14.91M | 0 | -14.26M | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -14.01M | -27.79M | -15.87M | -3.27M | 3.18M | 152.53K | 52.85M | 0 | 0 | 663 |
Net Change In Cash | -2.64M | -3.37M | -2.53M | 2.97M | 5.93M | -561.31K | -2.46M | 2.09M | 1.64M | 1.07M |
Cash at end of period | 3.91M | 6.56M | 9.94M | 12.48M | 9.50M | 3.57M | 4.13M | 6.60M | 4.51M | 2.86M |
| Data source | Data source |